Structure-based pharmacophore clustering of multi-conformation proteins

Application to identify novel and diverse CypD inhibitors

S. M. Fayaz, G. K. Rajanikant

Research output: Contribution to journalArticle

Abstract

Objectives: Cyclophilin D (CypD) is a chief regulatory protein of the necroptosis pathway involved in various neurological disorders, and ablation/inhibition of this protein confers neuroprotection. Current in silico drug design strategies employ multiple structures of a protein target since they enable the identification of diverse inhibitor molecules. However, structure-based drug design against a protein target becomes challenging if it contains numerous known structures with varying ligand interactions. Considering all these structures for virtual screeing of database compounds would be inappropriate in view of the computational resources that might be demanded. Therefore, identifying appropriate structures with varied binding site conformations is of utmost importance in order to identify inhibitors with diverse scaffolds. Method: In the present study, clustering of a large number of CypD structures was carried out by comparing the pharmacophores derived from their binding sites. A representative structure from each cluster was adopted to build an ensemble pharmacophore that was further employed in dual ensemble screening of database compounds. Results: Two compounds that exhibited better docking scores, compared to the already reported CypD inhibitors, formed stable complexes and desirable interactions with the protein during molecular dynamics (MD) simulation.

Original languageEnglish
Pages (from-to)224-233
Number of pages10
JournalCurrent Proteomics
Volume14
Issue number3
DOIs
Publication statusPublished - 01-09-2017

Fingerprint

Protein Conformation
Cluster Analysis
Conformations
Drug Design
Proteins
Binding Sites
Databases
Molecular Dynamics Simulation
Ablation
Nervous System Diseases
Scaffolds
Pharmaceutical Preparations
Computer Simulation
Molecular dynamics
Screening
cyclophilin D
Ligands
Molecules
Computer simulation

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology

Cite this

@article{5da7e163faa346669f2030b50b84a4af,
title = "Structure-based pharmacophore clustering of multi-conformation proteins: Application to identify novel and diverse CypD inhibitors",
abstract = "Objectives: Cyclophilin D (CypD) is a chief regulatory protein of the necroptosis pathway involved in various neurological disorders, and ablation/inhibition of this protein confers neuroprotection. Current in silico drug design strategies employ multiple structures of a protein target since they enable the identification of diverse inhibitor molecules. However, structure-based drug design against a protein target becomes challenging if it contains numerous known structures with varying ligand interactions. Considering all these structures for virtual screeing of database compounds would be inappropriate in view of the computational resources that might be demanded. Therefore, identifying appropriate structures with varied binding site conformations is of utmost importance in order to identify inhibitors with diverse scaffolds. Method: In the present study, clustering of a large number of CypD structures was carried out by comparing the pharmacophores derived from their binding sites. A representative structure from each cluster was adopted to build an ensemble pharmacophore that was further employed in dual ensemble screening of database compounds. Results: Two compounds that exhibited better docking scores, compared to the already reported CypD inhibitors, formed stable complexes and desirable interactions with the protein during molecular dynamics (MD) simulation.",
author = "Fayaz, {S. M.} and Rajanikant, {G. K.}",
year = "2017",
month = "9",
day = "1",
doi = "10.2174/1570164614666170206155848",
language = "English",
volume = "14",
pages = "224--233",
journal = "Current Proteomics",
issn = "1570-1646",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

Structure-based pharmacophore clustering of multi-conformation proteins : Application to identify novel and diverse CypD inhibitors. / Fayaz, S. M.; Rajanikant, G. K.

In: Current Proteomics, Vol. 14, No. 3, 01.09.2017, p. 224-233.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Structure-based pharmacophore clustering of multi-conformation proteins

T2 - Application to identify novel and diverse CypD inhibitors

AU - Fayaz, S. M.

AU - Rajanikant, G. K.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Objectives: Cyclophilin D (CypD) is a chief regulatory protein of the necroptosis pathway involved in various neurological disorders, and ablation/inhibition of this protein confers neuroprotection. Current in silico drug design strategies employ multiple structures of a protein target since they enable the identification of diverse inhibitor molecules. However, structure-based drug design against a protein target becomes challenging if it contains numerous known structures with varying ligand interactions. Considering all these structures for virtual screeing of database compounds would be inappropriate in view of the computational resources that might be demanded. Therefore, identifying appropriate structures with varied binding site conformations is of utmost importance in order to identify inhibitors with diverse scaffolds. Method: In the present study, clustering of a large number of CypD structures was carried out by comparing the pharmacophores derived from their binding sites. A representative structure from each cluster was adopted to build an ensemble pharmacophore that was further employed in dual ensemble screening of database compounds. Results: Two compounds that exhibited better docking scores, compared to the already reported CypD inhibitors, formed stable complexes and desirable interactions with the protein during molecular dynamics (MD) simulation.

AB - Objectives: Cyclophilin D (CypD) is a chief regulatory protein of the necroptosis pathway involved in various neurological disorders, and ablation/inhibition of this protein confers neuroprotection. Current in silico drug design strategies employ multiple structures of a protein target since they enable the identification of diverse inhibitor molecules. However, structure-based drug design against a protein target becomes challenging if it contains numerous known structures with varying ligand interactions. Considering all these structures for virtual screeing of database compounds would be inappropriate in view of the computational resources that might be demanded. Therefore, identifying appropriate structures with varied binding site conformations is of utmost importance in order to identify inhibitors with diverse scaffolds. Method: In the present study, clustering of a large number of CypD structures was carried out by comparing the pharmacophores derived from their binding sites. A representative structure from each cluster was adopted to build an ensemble pharmacophore that was further employed in dual ensemble screening of database compounds. Results: Two compounds that exhibited better docking scores, compared to the already reported CypD inhibitors, formed stable complexes and desirable interactions with the protein during molecular dynamics (MD) simulation.

UR - http://www.scopus.com/inward/record.url?scp=85029664703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029664703&partnerID=8YFLogxK

U2 - 10.2174/1570164614666170206155848

DO - 10.2174/1570164614666170206155848

M3 - Article

VL - 14

SP - 224

EP - 233

JO - Current Proteomics

JF - Current Proteomics

SN - 1570-1646

IS - 3

ER -